Clinical trial Recruiting at 1 site Interventional Ages 44 to 55 Women only

Daily prunes to slow bone loss during perimenopause

Official title: A Prevention Strategy for the Indication of Prune Consumption in Perimenopausal Females: Can Prunes Attenuate Bone Loss?

Run by Penn State University · NCT07120997 · Data updated 2026-11-12

This trial will test whether eating prunes daily for 18 months can slow bone loss in people going through perimenopause.

Quick facts

Study typeInterventional
Ages44 Years to 55 Years
SexWomen only
Enrollment124 (estimated)
SponsorPenn State University
Academic / other
Drugs / interventionsdenosumab, prednisone
Locations1 site (University Park, Pennsylvania)
StatusRecruiting
StartedDecember 11, 2025
Main results expectedSeptember 2029
Study endsDecember 2029
Registry record updatedFebruary 4, 2026
Trial IDNCT07120997 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy, non-smoking people aged 44–55 who are in the transmenopausal window (no menses for ≥60 days but ≤18 months), have BMI <35, a natural final menstrual period date, and are willing to eat prunes daily.

Probably not a fit

People with surgical menopause, prior fragility fractures, untreated thyroid or parathyroid disease, heavy regular prune or berry consumption, smokers, or BMI ≥35 may not benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants in the transmenopausal window will add prunes to their daily diet for up to 18 months while receiving standard calcium and vitamin D supplementation and clinical monitoring. Bone density at the spine and hip, blood tests, and safety measures will be collected over time to track changes in bone loss. The protocol excludes people with surgical menopause, prior fragility fractures, certain endocrine disorders, or heavy regular consumption of prunes/berries. If the intervention slows bone loss, it could be adopted widely as a low-cost dietary prevention strategy.

Why it matters

Potential benefit: If successful, eating prunes during the transmenopausal window could slow bone loss and lower the future risk of osteoporosis and fractures.

How similar studies have gone: Previous small trials of dried plums have shown promising bone-protective effects in postmenopausal women, but larger confirmatory trials are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 44 to 55 years
* Not severely obese (BMI \<35 kg/m\^2)
* Healthy (determined by a screening questionnaire, physical and medical history by a certified nurse practitioner, complete metabolic panel, and complete blood count)
* Willing to include prunes in their daily diet
* Not taking any natural dietary supplement containing phenolics, i.e.,\< 1 cup/day of blueberries or apples for at least 2 months prior to study entry
* Non-smoking
* Ambulatory
* No menses for ≥60 days but not more than 18 months post final menstrual period
* Only participants who have a determinable natural (not surgical) final menstrual period date are eligible

Exclusion Criteria:

* Subjects who regularly consume prunes, dried apples, prune juice, or heavy consumers of blueberries (1 cup or more/day)
* History of vertebral fracture or fragility fracture of the wrist, humerus, hip or pelvis after age 45 yr)
* Untreated hyper- or hypothyroidism
* Current hyper- or hypoparathyroidism
* Significantly impaired renal function
* Current hypo- or hypercalcemia
* History of spinal stenosis
* History of heart attack, stroke, thromboembolism, kidney disease, malabsorption syndrome, or seizure disorders
* Positive for HIV, Hep-C or Hep-B surface antigen and malignancy
* Use of the following agents affecting bone metabolism: intravenous bisphosphonates at any time; fluoride (for osteoporosis) within the past 24 months; denosumab at any time; bisphosphonates, parathyroid hormone or strontium within the past 12 months; calcitonin; selective estrogen receptor modulators within the past 12 months; systemic oral or transdermal estrogen within the past 3 months; systemic glucocorticosteroids (≥ 5 mg prednisone equivalent per day for more than 10 days); or tibolone within the past 3 months
* Hormonal contraception within the past three months
* Subjects who will not consume study provided dietary items or who will not stop taking their own natural product supplements

Where it's running

  • Women's Health and Exercise Laboratory, The Pennsylvania State University
    University Park, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.